Adeboye Adewoye

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3,…

The Lancet Oncology · 2017 · 219 citations

A network model to predict the risk of death in sickle cell disease

Blood · 2007 · 129 citations